Christoph Schmid

Professor for SCT and cellular theray research

University of Augsburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christoph Schmid is a Professor for SCT and cellular therapy research at Augsburg University in Germany. His research focuses on the immune response in hematologic malignancies, with recent articles addressing topics such as dendritic cell modulation in acute myeloid leukemia, donor lymphocyte infusions in allogeneic stem cell transplantation, and molecular genetic analyses in hematologic conditions. His work contributes significantly to the understanding of therapeutic strategies and outcomes in cellular therapies.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Matthew Collin

Professor of Haematology

Newcastle University

UNITED KINGDOM

View details

Simona Pagliuca

FRANCE

View details

Hendrik Veelken

NETHERLANDS

View details

Hildegard Greinix

Division Head

Medical University of Graz

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christoph Schmid

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT

Dendritic Cells of Leukemic Origin (DCleu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation

Molecular Genetic Analysis of Bone Marrow Core Biopsy as an Alternative or Adjunct to Bone Marrow Aspirate and/or Peripheral Blood in Hematologic Myeloid Neoplasms

In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers

Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

A step closer to GVL without GVHD

Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies

Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party

Collaborators (4)

Matthew Collin

Simona Pagliuca

Hendrik Veelken

Hildegard Greinix

Make your next move.